Breast lesion localization method is used to diagnose breast lesion through various methods. Lesions may be benign or malignant. Breast lesion can lead to various symptoms such as tenderness, soreness, discharge and in some cases lumps. Breast lesion and lumps may occur gradually and may be accompanied with several symptoms such as pain, changes in skin and changes in nipple. Breast lesion can be caused by breast cyst, mastitis, lipoma, Fibroadenomas, and Phyllodes tumor, among others. Certain proliferative breast lesions can lead to breast cancer. Thus, increasing incidence of breast cancer necessitates early detection of symptoms, with breast lesion localization being among the very basic tests conducted for the same. Increasing incidence of breast cancer and rising focus on early detection of the same is in turn expected to lead to rapid growth the global breast lesion localization market.
To know the latest trends and insights prevalent in the Breast Lesion Localization Methods Market, click the link below:
Rising focus on early detection to combat growing incidence of breast cancer to fuel growth of breast lesion localization methods market
Growth in adoption of breast lesion localization methods is directly related to steep rise in incidence of breast cancer and subsequently increasing focus on early detection of related symptoms in order to ensure timely treatment and in turn increase survival rate. As per statistics released by World Cancer Research Fund International, breast cancer was the most common type of cancer among women, with around 1.7 million new cases detected in 2012, accounting for 25% of cancer among women. According to American Cancer Society, around 40,290 deaths were reported in the U.S., related to breast cancer. Increasing number of breast awareness campaigns such as ‘Breast Awareness Campaign’ by The Estée Lauder Companies Inc., ‘Think Before You Pink’ by Breast Cancer Action, and Breast Cancer Awareness Month (October 2017) by National Breast Cancer Foundation, Inc. promotes uptake of breast cancer screening test and thus creates a highly conducive environment for growth of the breast lesion localization methods market. Favorable reimbursement scenario such as coverage under Medicare further fuels market growth.
Radio-guided occult lesion localization is increasingly being preferred over conventional wire-guided localization. This is mainly attributed to better outcomes of ROLL technique as it reduces localization and operation time, prevents healthy tissue excision and helps achieve clearer margins as compared to wire-localization techniques as revealed by statistics released by the National Center for Biotechnology Information. However, concerns regarding exposure to radiation and stringent and time consuming regulatory approval process inhibit market growth to a certain extent.
Request Report Sample for more Professional and Technical Insights,
Global breast lesion localization methods market taxonomy
The global breast lesion localization methods market is classified on the basis of the following segments:
- Product Type:
- Wire Localization
- Core Biopsy Needles
- Fine Aspiration
- Radioisotope Localization
- Radioactive Seed Localization
- Radio Occult Lesion Localization
- Magnetic Tracers
- Other Localization Methods
- End Users:
- Ambulatory Surgical Centers
- Diagnostic Centers
- Oncology Centers
Ask for Discount @ https://www.coherentmarketinsights.com/insight/request-discount/104
Major Breast Lesion Localization Method: Temno biopsy device (Becton, Dickinson and Company.), Adjustable Coaxial Temno biopsy device (Becton, Dickinson and Company), SAVI SCOUT (Cianna Medical) , Repomark (MDL), Kopans (Cook Medicals), Mark (MDL), Hawkins (Argon Medical).
Developed Markets still not achieved Maturity for breast lesion localization method
Developed economies such as the U.S., U.K. and Germany experience high rate of adoption due to growing concern towards breast cancer and high concentration of experienced practitioners in these countries. The trend is expected to continue in the near future. As per the report of the Breast Cancer organization about one in every eight women in the U.S. are expected to develop breast cancer in their lifetime. Low awareness among the populace in emerging economies constrains market growth in the region, though increasing awareness programs being initiated in the region along with increasing incidence of breast cancer is projected to position these regions as lucrative markets over the forecast period (2016–2024).
Devices with Comprehensive Range of Features
There are new devices being launched with additional features and technology. Cook’s breast lesion localization product was launched with procedural precision. The product is used preoperative marking of non-palpable breast lesion. In 2009, Dilon Diagnostic’s cornerstone received U.S. FDA approval for its GammaLMc, which could locate lesion through gamma guided biopsy. Companies are focusing on introducing new products with innovative features and technology in order to overcome complications such as infections and genetic mutations due to radiations, associated with breast lesion localizations.
The global breast lesion localization methods market is highly fragmented owing to the participation of many established and emerging players in the breast lesion localization methods market. Major players involved in the breast lesion localization methods market include SOMATEX Medical Technologies, Tsunami Medical, Sterylab, MDL, Biomedical, Cook Medical, and Argon Medical.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154